This Solicitation opportunity from Department Of Defense was posted on August 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
TRAZODONE TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract solicitation SPE2DP-26-T-4520 is for the procurement of Trazodone Hydrochloride Tablets, 100 mg, in bottle units of 100 tablets each, with a total quantity of three bottles. The item is regulated by the FDA and must comply with strict medical supply standards, including a non-extendable 24-month shelf life, with no less than 21 months remaining at the time of delivery to the government. Packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, which supersedes MIL-STD-129 for all non-radioactive medical items. Each unit must be sealed in a protective container, and shipping containers must ensure safe delivery via common carrier at the lowest cost, with palletization following DLA Packaging Requirements for Procurement (RP001). For non-hazardous materials, commercial packaging must meet ASTM D3951, but DLA Master List requirements take precedence. The drug must be shipped FOB destination to Fort Bragg, North Carolina, within 20 days of the government’s order instruction, with delivery required no later than August 7, 2026, and must be transported using traceable methods—parcel post is prohibited. The contracting officer must submit a referral to the product specialist to confirm eligibility of suppliers, including TEVA Pharmaceuticals USA, Inc., Apotex Corp., and Mead Johnson & Company, LLC, each identified by their NDC numbers. Payment must be processed electronically through WAWF, and all offerors must hold a valid UEI and CAGE code, and submit representations regarding small business status, socioeconomic certifications, and compliance with trafficking in persons, employment eligibility, and cybersecurity requirements under FAR and DFARS clauses. The contract includes requirements for safeguarding controlled defense information, prohibitions on certain foreign-sourced telecommunications equipment, and hazard communication standards, with all packaging marked to meet DLA’s technical and quality specifications. The solicitation is conducted electronically via DIBBS with no physical submissions accepted, and the award will be based on compliance and price, though no evaluation methodology or weighting is explicitly stated.
General Info
Place of Performance
BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
TRAZODONE HYDROCHLORIDE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
100 MG, BOTTLE OF 100'S
U/I "BOTTLE"
SHALL HAVE A SHELF LIFE OF 24 MONTHS.
NOT LESS THAN 21 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO
DATE OF DELIVERY TO THE GOVERNMENT.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4520
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
MEAD JOHNSON & COMPANY, LLC 29398 P/N NDC00087-0776-41 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC50111-0561-01 APOTEX CORP. 4PX51 P/N NDC60505-2654-01
TDP Rev A Gen 1 IAW REFERENCE REVISION NR DTD PART PIECE NUMBER:
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017754804 0001 BT 3.000
NSN/MATERIAL:6505011370032
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
SPE2DP-26-T-4520
SECTION B
PR: 7017754804 PRLI: 0001 CONT’D
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262160132
RDD: 230
PROJ: TP 2
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:08/07/2026
SPE2DP-26-T-4520 NSN/Part Number: 6505-01-137-0032 Quantity: 3 BT Purchase Request: 7017754804QTY: 3 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
